AzTrials
AzTrials

Cleft PalateNCT07840911

Furlow With Buccinator and Fistula Formation

A study testing furlow with buccinator and two flap palatoplasty in people with Cleft Palate, run by Fayoum University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Furlow with buccal myomucosal flap (group 1) Local anesthesia with a vasoconstrictor will be injected at the beginning of the surgery after Z- flap outline marking. On the left side, myomucosal posteriorly based flap will be incised containing the levator palateni muscle with a 60◦ angle and elevated. Read more about this study

Who is it for?
Ages 9 to 12 months
Conditions the study is for
Cleft Palate
What is being tested?
furlow with buccinator and two flap palatoplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
25 Sep 2026to 30 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 9-12 months old childreen with complete cleft lip and palate, nonsyndromic.
  • lip and palate repair performed by one craniofacial surgeon

Who cannot join

  • Patients with syndromic cleft lip.
  • Redu cases
  • Bilateral cleft lip
  • Associated Cardiac anomalies.
  • Any systemic condition

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Shaimaa Refahee contact

01227407987

smr11@fayoum.edu.eg

About this study

Official title: • Fistula Formation in Patients With Cleft Palate Following Primary Furlow Palatoplasty With Buccal Myomucosal Flap Versus Two Flap Palatoplasty

Furlow with buccal myomucosal flap (group 1) Local anesthesia with a vasoconstrictor will be injected at the beginning of the surgery after Z- flap outline marking. On the left side, myomucosal posteriorly based flap will be incised containing the levator palateni muscle with a 60◦ angle and elevated. Another small anteriorly-based nasal mucosa flap will be created. On the opposite side, oral mucosal anteriorly based flap with a 90◦ angle will be incised and elevated. Palatal muscle will be stripped and posteriorly based myomucosal flap was created containing palatal muscle and nasal mucosa. Nasal mucosa will be sutured followed by oral mucosa with minimal palatal muscle overlapping. The oral mucosa defect will be filled with BMMF Two flap palatoplasty surgical steps (group 2) A bilateral tongue like palatal flaps will be incised and elevated from the incisive foramen anteriorly to the hamulus posteriorly medial to the teeth and extended around the cleft area. Palatal muscles will be detached from the palatal shelves and separating it from the nsal mucosa. Nasal layer will be the firstly closed, followed by the muscle and oral mucosal layers. In case of the presence of a bare area of bone, it will be left to heal by secondary intention

Conditions
Cleft Palate
Being tested
furlow with buccinator, two flap palatoplasty
Keywords
cleft palate, fistula
Medical subject headings
Cleft Palate, Fistula

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • furlow with buccinatorProcedure or surgery

    clefted patients were treated with furlow with buccinator flap

  • two flap palatoplastyProcedure or surgery

    clefted patients were treated with two flap palatoplasty

Study groups in NCT07840911
Study groupRoleWhat they receive
furlow with buccinatorExperimentalNot described
Receives: Procedure: furlow with buccinator
two flap palatoplastyActive comparatorNot described
Receives: Procedure: two flap palatoplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. fistula formation

    assessment the fistula formation after cleft palate repair by determination the site of fistula and time at which appear

    Measured: 6 months postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2026
  2. Study start25 Sep 2026 (estimated)
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07840911
Sponsor's protocol ID
44
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing furlow with buccinator and two flap palatoplasty in people with Cleft Palate, run by Fayoum University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shaimaa Refahee (01227407987, smr11@fayoum.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

fistula formation (time frame: 6 months postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in